Carvedilol Tablet, Film Coated
Product Images NDC 53401-045

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Carvedilol (NDC 53401-045). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carvedilol Chemical Structure (Carvedilol Tab Usp Structure)

Chemical structure of carvedilol, showing its molecular framework including aromatic rings, hydroxyl group, ether linkages, and amine functionalities.*

FDA Label Image

Figure 1. Survival Analysis For Copernicus (intent-to-treat) (Carvedilol Tab Usp Figure1)

A line chart depicting percent mortality over a 21-month period comparing Carvedilol and placebo groups. The x-axis represents time in months, and the y-axis shows percent mortality. The Carvedilol group has a consistently lower mortality rate than the placebo group, with a p-value of 0.0014 indicated on the chart.*

FDA Label Image

Figure 2. Effects On Mortality For Subgroups In Copernicus (Carvedilol Tab Usp Figure2)

A forest plot showing hazard ratios with confidence intervals for various subgroups including men, women, age groups (<65 and ≥65), racial categories (Black and Non-black), diabetic status, ischemic condition, heart rate, systolic blood pressure levels, and spironolactone use. The x-axis represents the hazard ratio from 0.0 to 2.0, with a reference line at 1.0.*

FDA Label Image

Figure 3. Survival Analysis For Capricorn (intent-to-treat) (Carvedilol Tab Usp Figure3)

A line graph showing percent mortality over 24 months comparing two groups: Carvedilol and Placebo. The y-axis represents % Mortality from 0 to 30, and the x-axis represents time in months from 0 to 24. The Carvedilol group shows lower mortality over time compared to the Placebo group, with a p-value of 0.03 indicated on the graph.*

FDA Label Image

Figure 4. Effects On Mortality For Subgroups In Capricorn (Carvedilol Tab Usp Figure4)

A forest plot showing hazard ratios with 95% confidence intervals for various patient subgroups related to medical conditions and treatments (e.g., age, sex, prior treatments, heart rate, blood pressure). The horizontal axis indicates hazard ratio values ranging from 0.4 to 1.3, with a dashed vertical line at 1.0 representing no effect.*

FDA Label Image

Aphena (Aphena)

FDA Label Image

Label (53401 0045 80)

Label for Carvedilol USP 6.25 mg film-coated tablets, containing 180 tablets. The label includes storage instructions, manufacturer information (Rubicon Research Ltd., Thane, India), and repackager information (Aphena Pharma, Cookeville, TN). It specifies the product is prescription only and includes an NDC number 53401-045-80 along with batch and expiration placeholders.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.